KRAS-activating mutations: an independent risk factor for VTE?
Colorectal cancer (CRC) is the third most common type of cancer in Europe , after breast and prostate cancer, and...
News
Challenges in the management of fragile CAT patients (older patient population & palliative care)
Our speakers, Jay Easaw, Thomas R.J. McFarlane, and Simon Noble shared some updates on the management of fragile CAT...
VTE in Palliative Care Patients: What do we know? A talk report from the 10th ICTHC
During the 10th ICTHIC, Professor Simon Noble (Cardiff University, UK) talked about the management of VTE in patients...
VTE risk in patients with lung cancer
Lung cancer is associated with a very high risk of developing venous thromboembolism (VTE). In a large...
Cancer-associated thrombosis: mechanisms and risk factors
Blood clot generation in people with cancer follows a process distinct from the non-cancer population. Cancer tissue is...
D-dimer and its role in venous thromboembolism
D-dimer is a marker of coagulation activation and thrombotic activity. The analysis of D-dimer levels is used to...
European Week Against Cancer
ICTHIC Magazine is happy to support the European Week Against Cancer organized by the European Cancer Patient...
Update on Oncology & Thrombosis to include COVID‐19. Your questions answered by our speakers
During our webinar “Update on Oncology & Thrombosis to include COVID‐19”, the interest from the audience was...
UPDATE: 10th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will go virtual....
SAVE THE “NEW” DATE!
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will be held in Bergamo...